CD40LG and rheumatoid arthritis: To analyse the relative risk of developing RA, carriage of the PTPN22 1858T variant was combined with anti-CCP antibodies, RFs (IgG-RF, IgA-RF and IgM-RF) and with HLA-SE in conditional logistic regression analyses.